Diabetic Retinopathy Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

Diabetic Retinopathy Market Size was valued at USD 8 billion in 2018 and is expected to witness a 6% CAGR from 2021 to 2027.

Diabetes is a lifelong chronic disease caused by excessive accumulation of glucose in the blood due to a lack or lack of the insulin hormone that metabolizes glucose in the blood. The level of glucose accumulated in the blood does not reach the cells of the body and has a serious effect on many organs such as the kidneys, eyes, nerves, blood vessels, and heart. Diabetic retinopathy is one of the common diabetic eye diseases characterized by damaged blood vessels in the retina. Damaged blood vessels and nerves lead to blurred vision, impaired vision, and eye bleeding. If left untreated, it can lead to retinal detachment and blindness. Nonproliferative diabetic retinopathy (NDPR) and proliferative diabetic retinopathy (PDR) are two stages of diabetic retinopathy. Diabetic retinopathy can be treated with medicines, laser surgery, and vitrectomy. Diabetic retinopathy can occur in any individual with type 1 or type 2 diabetes. This disease is the leading cause of blindness in the United States.

Market Segments

By Type

• Non-Proliferative
• Proliferative

By Treatment

• Anti- VEGF Drugs
• Laser Photocoagulation
• Vitreoretinal Surgery
• Steroid Injection

By End-User

• Hospitals
• Ambulatory Surgical Centers
• Others

Key Players

Some of the major industry players operatives in the diabetic retinopathy market include Novartis, Regeneron Pharmaceuticals, Genentech, Allergan and Bayer AG, Aerpio Pharmaceuticals, Ampio Pharmaceuticals, BCN Peptides, ThromboGenics, Kowa Company, and Alimera Sciences.

Scope of the Report

The research study analyzes the global Diabetic Retinopathy industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Diabetic Retinopathy Market Report

1. What was the Diabetic Retinopathy Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027). 2. What will be the CAGR of the Diabetic Retinopathy Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Diabetic Retinopathy Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.